Zhang Qiao, Bosch-Rué Èlia, Pérez Román A, Truskey George A
Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708, USA.
Bioengineering Institute of Technology (BIT), Universitat Internacional de Catalunya (UIC), Sant Cugat del Vallès 08195, Spain.
APL Bioeng. 2021 May 7;5(2):021507. doi: 10.1063/5.0039628. eCollection 2021 Jun.
Cardiovascular disease (CVD) is the leading cause of death among persons aged 65 and older in the United States and many other developed countries. Tissue engineered vascular systems (TEVS) can serve as grafts for CVD treatment and be used as model systems to examine the role of various genetic factors during the CVD progressions. Current focus in the field is to fabricate TEVS that more closely resembles the mechanical properties and extracellular matrix environment of native vessels, which depends heavily on the advance in biofabrication techniques and discovery of novel biomaterials. In this review, we outline the mechanical and biological design requirements of TEVS and explore the history and recent advances in biofabrication methods and biomaterials for tissue engineered blood vessels and microvascular systems with special focus on applications. applications of TEVS for disease modeling are discussed.
心血管疾病(CVD)是美国及许多其他发达国家65岁及以上人群的主要死因。组织工程血管系统(TEVS)可作为治疗CVD的移植物,并用作模型系统来研究各种遗传因素在CVD进展过程中的作用。该领域目前的重点是制造更接近天然血管机械性能和细胞外基质环境的TEVS,这在很大程度上依赖于生物制造技术的进步和新型生物材料的发现。在这篇综述中,我们概述了TEVS的机械和生物学设计要求,并探讨了用于组织工程血管和微血管系统的生物制造方法和生物材料的历史及近期进展,特别关注其应用。还讨论了TEVS在疾病建模中的应用。